Jim Cramers Monthly Meeting Review 33 Portfolio Stocks Highlighted With 4 Potential Opportunities The Federal Reserves Path to Rate Cuts Narrows Amid Stubborn Cost of Living Pressures Bank of America Forecasts 10x Productivity Boost from AI as Implementation Gap Narrows UK Startup BioOrbit Launches DrugMaking Technology to Space for Cancer Treatment Global Markets Rally as Middle East Peace Hopes Boost Risk Appetite Jim Cramer Focus on AI Stocks Upside Potential Not Past Performance SHC Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Pullback SABS Q1 2026 Earnings WiderthanExpected Loss as Biotech Continues Development Shares Edge Higher Worthington Enterprises Inc WOR Q1 2026 Earnings EPS Slightly Beats Estimates Amid Steady Operations MDLN Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response HYPD Q1 2026 Earnings Significant EPS Miss Weighs on Investor Sentiment GHC Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiency Montauk Renewables MNTK Edges Higher as Stock Finds Support Near 147 MannKind Corporation MNKD Surges 44 Testing Key Resistance Amid Biotech Momentum Adobe Stock Edges Higher as Investors Eye Key Resistance Levels Ryvyl Inc RVYL Holds Steady at 781 as Traders Await Breakout from Tight Range Icahn Enterprises IEP Holds Steady Near 755 as Trading Volume Remains Subdued OpenAI Poised for Confidential IPO Filing Signaling Race to Public Markets Cerence Inc CRNC Q1 2026 Earnings EPS Beat Slightly Offsets Market Skepticism State Street STT Edges Lower Stays Within Range Near Key Support